Cardinal Health, Inc. (NYSE:CAH) Holdings Decreased by Versant Capital Management Inc

Versant Capital Management Inc reduced its holdings in Cardinal Health, Inc. (NYSE:CAH) by 15.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,209 shares of the company’s stock after selling 403 shares during the period. Versant Capital Management Inc’s holdings in Cardinal Health were worth $261,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Commonwealth Equity Services LLC increased its stake in shares of Cardinal Health by 1.5% in the second quarter. Commonwealth Equity Services LLC now owns 77,527 shares of the company’s stock worth $7,623,000 after acquiring an additional 1,177 shares during the last quarter. Van ECK Associates Corp increased its position in Cardinal Health by 10.2% in the 2nd quarter. Van ECK Associates Corp now owns 30,489 shares of the company’s stock worth $2,998,000 after purchasing an additional 2,833 shares during the last quarter. TIAA Trust National Association raised its stake in shares of Cardinal Health by 14.1% during the 2nd quarter. TIAA Trust National Association now owns 2,138 shares of the company’s stock worth $210,000 after purchasing an additional 264 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its holdings in shares of Cardinal Health by 0.5% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 20,891 shares of the company’s stock valued at $2,054,000 after buying an additional 100 shares during the last quarter. Finally, Foundations Investment Advisors LLC grew its stake in shares of Cardinal Health by 5.5% in the 2nd quarter. Foundations Investment Advisors LLC now owns 5,874 shares of the company’s stock valued at $578,000 after buying an additional 305 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

NYSE CAH opened at $119.30 on Friday. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $126.23. The stock has a market cap of $28.87 billion, a PE ratio of 23.21, a PEG ratio of 1.47 and a beta of 0.63. The firm has a 50-day simple moving average of $118.80 and a 200 day simple moving average of $110.37.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.73 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.70%. Cardinal Health’s dividend payout ratio (DPR) is currently 39.30%.

Analysts Set New Price Targets

CAH has been the subject of a number of analyst reports. Morgan Stanley lifted their target price on shares of Cardinal Health from $127.00 to $136.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. Barclays upped their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Wells Fargo & Company upgraded Cardinal Health from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $101.00 to $127.00 in a report on Friday, December 13th. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Finally, UBS Group raised their price objective on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $127.50.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.